MedPath

The Effects of Dexmedetomidine on Postoperative Cognitive Function in Open Heart Surgery

Not Applicable
Recruiting
Conditions
Open Heart Sugery
Neuronal Damage
Interventions
Registration Number
NCT06655025
Lead Sponsor
Sohag University
Brief Summary

To assess the impact of Dexmedetomidine on postoperative cognitive function and serum Neuron Specific Enolase levels as an indicator of neuronal injury in patients undergoing open heart surgery

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Patients of both sexes undergoing elective open-heart surgery
Exclusion Criteria
  • Patients with a history of neurological disorders, severe renal or liver dysfunction, or contraindications to Dexmedetomidine as in patients with known QT prolongation, a history of other arrhythmias, symptomatic bradycardia, hypokalemia, or hypomagnesemia, and in patients receiving other drugs known to prolong the QT interval.

Patients with cognitive impairment, mental and psychological illness and chronic alcoholics, drug addicts, abuse of psychotropic substances, illiterate education

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group B (Dexmedetomidine)DexmedetomidineDexmedetomidine infusion
Group A (control)Dexmedetomidinenormal saline infusion
Primary Outcome Measures
NameTimeMethod
postoperative cognitive functionpre- oprerative , Mini-mental state examination (MMSE) will be performed at 1, 3 and 7 days after operation.

using the Mini-Mental State Examination (MMSE) to evaluate cognitive status

Secondary Outcome Measures
NameTimeMethod
serum Neuron Specific Enolase levelspre-operative ,post-operative 12 hours

serum Neuron Specific Enolase levels as an indicator of neuronal injury in patients undergoing open heart surgeries.

Trial Locations

Locations (1)

Sohag University

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath